CLINICAL_TRIALS
trial_result
· 2018-04-26
Clinical Trial Update: Efficacy of an Intranasal Testosterone Product [Phase 2]
Summary
Phase 2 trial results evaluate the efficacy of an intranasal testosterone product for hypogonadism; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Acerus Pharmaceuticals Corporation | Conditions: Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2018-04-26